Mainsail Partners, a growth equity firm based in Austin and San Francisco, appears to be reloading. It filed a Form D with ...
Keith Meister’s hedge fund Corvex Management has a 2.5% stake in the gene-sequencing machine maker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback